Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biotech stock crashes 50% after disclosing bad news from the FDA
Biotech stock crashes 50% after disclosing bad news from the FDA
Biotech stock crashes 50% after disclosing bad news from the FDA
Submitted by
admin
on April 26, 2016 - 9:45am
Source:
Yahoo/Business Insider
News Tags:
Sarepta Therapeutics
eteplirsen
FDA
Duchenne Muscular Dystrophy
Headline:
Biotech stock crashes 50% after disclosing bad news from the FDA
Do Not Allow Advertisers to Use My Personal information